Neutralization of CD40 and/or IL-21 reduced antibody production more effectively in pSS than in healthy controls in vitro; thus, the interruption of T and B-cell collaboration may be a potential therapeutic approach for down-regulating pathological humoral immunity in pSS. The gene discussed is CD40; the disease is peeling skin syndrome.